Spreadex Market Update

US data disappoints once more, markets look limp




There remains a discrepancy between the levels of the US markets, and the actual recovery the US is currently undergoing. The preliminary GDP for the fourth quarter was better than expected, but was still a drop from the last figure, whilst the Chicago PMI hit 5 and a half year lows, pending home sales missed its targets and the revised UoM consumer sentiment failed to match last month’s figure, despite an increase on the initial reading.

Whilst this data didn’t cause a precipitous fall, it cemented a weak end the month after the US markets had seen such explosive gains as late as Tuesday. Regardless, February will be remembered as the month where the Dow and S&P once more broke records and the NASDAQ edged even closer to its fabled 5000 level; yet this will paint a brighter picture than is accurate, with the US recovery still looking shakier than some would have you think.

Over in the Eurozone, the German vote to extend the Greek bailout deal did little to inspire growth in the markets, with the DAX et al. remaining at their pre-vote growth levels. However, this still leaves the German index at its latest all-time high, with the even more tantalising prospect of a Greek-free start to March. Despite the near-constant turmoil the region has been subjected to in February, it will come out in a very impressive position come closing time. And with ECB QE to start in earnest in March, its positive run may not have ended yet.

The FTSE edged back into the green this afternoon, and is on track to have gained nearly 150 points by the end of the month. Whilst this is paltry compared to the Dow Jones’ gains, the FTSE has managed to do this largely by borrowing the positive sentiment that has been the norm for the US and Eurozone markets in February.

Brent Crude looks like it finally end a month in the green, a rare sight since it began it declines, whilst copper looks set to be in a similar positive position. Gold’s situation, on the other hand, remains dire; whilst it has made a minor recovery this past week, it is still looking at ending February down by around $70 as the dollar continued to hamper the metal’s growth.



DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.